Quantcast
Channel: All News Releases
Viewing all 154736 articles
Browse latest View live

Multi-Housing Marketing Webinar – How to Build Your Property’s Digital Curb Appeal


New ‘Can’t Catch Harry’ Card Game from Odd 1s Out Surpasses $200,000 in Presales on Kickstarter

People’s Trust Home Insurance – First to Respond in Michael’s Wake

Catalent and Verastem Oncology Partner on Newly Launched, FDA Approved COPIKTRA™ (duvelisib) Capsules

$
0
0

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today welcomed the approval of Verastem Oncology’s COPIKTRA™ (duvelisib) capsules by the U.S. Food and Drug Administration (FDA). COPIKTRA is an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first approved dual inhibitor of PI3K-delta and PI3K-gamma, for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after at least two prior therapies.

(PRWeb October 16, 2018)

Read the full story at https://www.prweb.com/releases/catalent_and_verastem_oncology_partner_on_newly_launched_fda_approved_copiktra_duvelisib_capsules/prweb15844172.htm

Security Industry Association Forecasts 2019 Security Megatrends

Is Your Home Safe? Home Improvement Hosts, Danny Lipford & Chelsea Lipford Wolf, Share Expert Tips in National Media Event

The Rise of the Recurring and Subscription Payments Market

FitVine Wine Introduces A Low Sugar, Low Sulfite Prosecco


Censis Technologies Acquires Applied Logic

Chain Business Insights New eBook on Blockchain in Smallholder Farming Investigates How Blockchain Technology Could Help Alleviate Poverty and World Hunger

$
0
0

Research provides valuable insights to stakeholders across agricultural supply chains such as farm organizations, food manufacturers and retailers, providers of services and farm inputs, transportation and logistics companies, government agencies and NGOs.​

(PRWeb October 16, 2018)

Read the full story at https://www.prweb.com/releases/chain_business_insights_new_ebook_on_blockchain_in_smallholder_farming_investigates_how_blockchain_technology_could_help_alleviate_poverty_and_world_hunger/prweb15840305.htm

Sneakers Agency Founder Featured in Samsung Podcast: How to Develop the Killer App for Business

Cubelets Discovery Set From Modular Robotics Now Available for the Holiday Season

New Custom Embroidered Patches for Hats Offers Additional Pricing Options for Wholesale Hat Buyers

Clinerion and S4 Research Partner to Accelerate the Introduction of Innovative Medical Treatments to India

Simulations From Marketplace, Cesim, and MobLab Now Available From Harvard Business Publishing Education


Immicompliance – The Best Choice For Immigration Software

Chattanooga and Ooltewah, TN’s Leading Cellphone Repair Store Cell Surgeon Announces Total Rebranding

Free People Beauty & Wellness Launches A Collection of All-Natural Fine Fragrances

ERS Genomics and Syngulon Sign License Agreement on CRISPR-Cas9 Genome Editing Patents for Industrial Applications

$
0
0

ERS Genomics Ltd and Syngulon, a synthetic biology startup developing original genetic technologies using bacteriocins, announced today a non-exclusive license agreement which provides Syngulon with worldwide access to ERS’ CRISPR-Cas9 genome editing intellectual property for use in combination with Syngulon Patent Rights.

(PRWeb October 17, 2018)

Read the full story at https://www.prweb.com/releases/ers_genomics_and_syngulon_sign_license_agreement_on_crispr_cas9_genome_editing_patents_for_industrial_applications/prweb15840777.htm

Pathbuilders Percepta® Developing the Next Generation of Leaders

Viewing all 154736 articles
Browse latest View live




Latest Images